PL1989182T3 - Postać krystaliczna soli peryndoprylu z argininą, sposób jej wytwarzania i kompozycje farmaceutyczne ją zawierające - Google Patents

Postać krystaliczna soli peryndoprylu z argininą, sposób jej wytwarzania i kompozycje farmaceutyczne ją zawierające

Info

Publication number
PL1989182T3
PL1989182T3 PL07731039.9T PL07731039T PL1989182T3 PL 1989182 T3 PL1989182 T3 PL 1989182T3 PL 07731039 T PL07731039 T PL 07731039T PL 1989182 T3 PL1989182 T3 PL 1989182T3
Authority
PL
Poland
Prior art keywords
perindopril
preparing
pharmaceutical compositions
crystalline form
arginine salt
Prior art date
Application number
PL07731039.9T
Other languages
English (en)
Inventor
Gérard Coquerel
Loïc Lefebvre
Jean-Claude Souvie
Pascale Authouart
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37022969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1989182(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of PL1989182T3 publication Critical patent/PL1989182T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL07731039.9T 2006-02-28 2007-02-26 Postać krystaliczna soli peryndoprylu z argininą, sposób jej wytwarzania i kompozycje farmaceutyczne ją zawierające PL1989182T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0601748A FR2897866B1 (fr) 2006-02-28 2006-02-28 Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
PL1989182T3 true PL1989182T3 (pl) 2016-09-30

Family

ID=37022969

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07731039.9T PL1989182T3 (pl) 2006-02-28 2007-02-26 Postać krystaliczna soli peryndoprylu z argininą, sposób jej wytwarzania i kompozycje farmaceutyczne ją zawierające

Country Status (27)

Country Link
US (1) US7846961B2 (pl)
EP (1) EP1989182B1 (pl)
JP (1) JP5255454B2 (pl)
KR (2) KR20120001818A (pl)
CN (1) CN101389603B (pl)
AU (1) AU2007220435B2 (pl)
BR (1) BRPI0708278B8 (pl)
CA (1) CA2644467C (pl)
CY (1) CY1117753T1 (pl)
DK (1) DK1989182T3 (pl)
EA (1) EA014716B1 (pl)
ES (1) ES2581982T3 (pl)
FR (1) FR2897866B1 (pl)
GE (1) GEP20125433B (pl)
HR (1) HRP20160644T1 (pl)
HU (1) HUE027898T2 (pl)
MA (1) MA30276B1 (pl)
ME (1) ME02456B (pl)
MY (1) MY151035A (pl)
NO (1) NO20083535L (pl)
NZ (1) NZ570367A (pl)
PL (1) PL1989182T3 (pl)
RS (1) RS54754B1 (pl)
SI (1) SI1989182T1 (pl)
UA (1) UA89905C2 (pl)
WO (1) WO2007099217A1 (pl)
ZA (1) ZA200807024B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2318365T3 (en) 2008-06-24 2015-11-23 Mylan Lab Ltd NOVEL polymorphic forms of perindopril (L) -arginine AND PROCESS FOR PREPARATION THEREOF
AU2009212902A1 (en) 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
FR2985511B1 (fr) * 2012-01-05 2014-01-03 Servier Lab Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2985512B1 (fr) * 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
CN103172696B (zh) * 2012-12-19 2014-12-17 宁波美诺华药业股份有限公司 一种γ晶型的培哚普利精氨酸盐的制备方法
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
SI26268A (sl) 2021-11-18 2023-05-31 Zupet Rok Postopek za pripravo hidratirane oblike perindopril l-arginina
CN114149357B (zh) * 2021-12-29 2024-06-25 江苏嘉逸医药有限公司 一种γ晶型培哚普利精氨酸盐的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
FR2897865B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
DK2318365T3 (en) 2008-06-24 2015-11-23 Mylan Lab Ltd NOVEL polymorphic forms of perindopril (L) -arginine AND PROCESS FOR PREPARATION THEREOF

Also Published As

Publication number Publication date
BRPI0708278B1 (pt) 2021-03-02
HRP20160644T1 (hr) 2016-07-01
BRPI0708278A2 (pt) 2011-05-24
CA2644467C (fr) 2011-07-26
SI1989182T1 (sl) 2016-07-29
NZ570367A (en) 2011-03-31
GEP20125433B (en) 2012-03-26
ZA200807024B (en) 2010-04-28
CY1117753T1 (el) 2017-05-17
HUE027898T2 (en) 2016-10-28
KR20120001818A (ko) 2012-01-04
MA30276B1 (fr) 2009-03-02
CA2644467A1 (fr) 2007-09-07
EA200801777A1 (ru) 2009-02-27
KR20080106948A (ko) 2008-12-09
UA89905C2 (ru) 2010-03-10
MY151035A (en) 2014-03-31
RS54754B1 (sr) 2016-10-31
EP1989182A1 (fr) 2008-11-12
CN101389603A (zh) 2009-03-18
BRPI0708278B8 (pt) 2021-05-25
DK1989182T3 (en) 2016-07-25
JP5255454B2 (ja) 2013-08-07
US20090203758A1 (en) 2009-08-13
EA014716B1 (ru) 2011-02-28
EP1989182B1 (fr) 2016-04-13
ME02456B (me) 2017-02-20
HK1129669A1 (en) 2009-12-04
AU2007220435A1 (en) 2007-09-07
NO20083535L (no) 2008-08-14
FR2897866A1 (fr) 2007-08-31
FR2897866B1 (fr) 2008-04-18
JP2009534295A (ja) 2009-09-24
CN101389603B (zh) 2012-07-04
US7846961B2 (en) 2010-12-07
ES2581982T3 (es) 2016-09-08
AU2007220435B2 (en) 2010-11-04
WO2007099217A1 (fr) 2007-09-07

Similar Documents

Publication Publication Date Title
SI1989182T1 (sl) Kristalinična oblika argininske soli perindoprila, postopek za njeno pripravo in farmacevtski sestavki, ki jo vsebujejo
SI1752443T1 (sl) Nova kristalinična oblika V agomelatina, postopek za njeno pripravo in farmacevtski sestavki, ki jo vsebujejo
IL212464A0 (en) Process for the preparation of protected l-alanine derivatives
IL190137A (en) Lacquinimod crystalline mixtures, pharmaceutical compositions containing them and ways to prepare them
IL203292A (en) History of n-indazolil affluent, process for preparation, intermediates obtained in this process and pharmacological preparations containing the history
IL198847A0 (en) New process for the preparation of 2-imino-thiazolidin-4-one derivatives
IL208203A (en) Annotations of 3,2-Dihydro-Pyrido-4,1-Exazine and 3,2-Dihydro-4-Oxa-9,1-Diazapananthrene, Preparation Processes and Pharmaceutical Preparations
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
PL1695709T3 (pl) Postać krystaliczna gamma-d chlorowodorku iwabradyny, sposób jej wytwarzania i kompozycje farmaceutyczne zawierające tę postać
PL2210872T3 (pl) Nowa postać krystaliczna III agomelatyny, sposób jej wytwarzania i kompozycje farmaceutyczne ją zawierające
IL218539A (en) Annotated 4,1-Androsteadian-3-Oxo-9,6-Dihlo-16-Isoxazolidine-17-Noble N-Converted
IL188069A0 (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
HUP0600809A2 (en) New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
SI2231598T1 (sl) Novi derivati diazeniumdiolata postopek pripravele teh in njihovi farmacevtski sestavki
IL205082A0 (en) Process for the preparation of tetranorlabdane derivatives
HUP0600808A3 (en) New benzamide derivatives as bradykinin antagonists, process for their preparation and pharmaceutical compositions containing them
HUP0600293A2 (en) Zinc salt of rosuvastatine, process for its preparation and pharmaceutical compositions containing it
PL2612850T3 (pl) Postać krystaliczna delta soli argininy peryndoprylu, sposób jej wytwarzania oraz kompozycje farmaceutyczne, które ją zawierają
ZA200902414B (en) Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
SI1707564T1 (sl) Indanil-piperazinski derivati, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
PL1979321T3 (pl) Nowe pirydynyloaminoalkileno- i pirydynyloksyalkileno- cyklopropanoaminy, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
ZA200902413B (en) Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
PL1753720T3 (pl) Proces wytwarzania peryndoprylu i jego soli
IL192963A0 (en) Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same
WO2009000909A3 (en) Salts of perindopril